September 24, 2020

Outcomes of the 2019 Novel Coronavirus in Patients with or without a History of Cancer: A Multi-Centre North London Experience

Category: Article Summary

Topic: Clinical Characteristics and Health Care Setting

Keywords (Tags): clinical characteristics, risk factors

• Cancer diagnosis did not increase risk of death (OR: 1.05, 95% CI: 0.4-2.5) or severe outcomes (OR: 0.9, 95% CI: 0.7-24.0) among a matched cohort of hospitalized patients with COVID-19 (n=120). Cancer patients who had received systemic treatment within 28 days prior to hospital admission appeared to have a nonsignificantly increased risk of death (OR: 4.05, 95% CI: 0.68-23.95).

Joharatnam-Hogan et al. (Jan 14, 2020). Outcomes of the 2019 Novel Coronavirus in Patients with or without a History of Cancer: A Multi-Centre North London Experience. Therapeutic Advances in Medical Oncology. https://doi.org/10.1177/1758835920956803